Royal Bank of Canada
ACHV icon

Royal Bank of Canada’s Achieve Life Sciences ACHV Stock Holding History

Royal Bank of Canada’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Sell
126
-1,410
-92% -$6.26K ﹤0.01% 7041
2025
Q4 		$8K Sell
1,536
-153,184
-99% -$668K ﹤0.01% 6504
2025
Q3 		$487K Buy
154,720
+36,786
+31% +$101K ﹤0.01% 4496
2025
Q2 		$266K Buy
117,934
+116,056
+6,180% +$331K ﹤0.01% 4943
2025
Q1 		$5K Sell
1,878
-2,282
-55% -$7.1K ﹤0.01% 6335
2024
Q4 		$15K Buy
4,160
+551
+15% +$2.5K ﹤0.01% 6214
2024
Q3 		$17K Buy
3,609
+370
+11% +$1.69K ﹤0.01% 6146
2024
Q2 		$15K Buy
+3,239
New +$15.6K ﹤0.01% 6171
2023
Q3 		– Sell
-500
Closed -$3K – 7021
2023
Q2 		$3K Buy
+500
New +$3.51K ﹤0.01% 6770
2022
Q4 		– Sell
-33,880
Closed -$112K – 7163
2022
Q3 		$112K Sell
33,880
-16,520
-33% -$78.8K ﹤0.01% 5223
2022
Q2 		$246K Buy
50,400
+10,000
+25% +$67.8K ﹤0.01% 4636
2022
Q1 		$306K Sell
40,400
-1,000
-2% -$7.45K ﹤0.01% 4693
2021
Q4 		$322K Buy
41,400
+9,500
+30% +$74.7K ﹤0.01% 4863
2021
Q3 		$271K Buy
31,900
+1,200
+4% +$9.41K ﹤0.01% 4887
2021
Q2 		$276K Buy
+30,700
New +$292K ﹤0.01% 4787
2020
Q3 		– Hold
0
– – – 6564
2020
Q2 		– Hold
0
– – – 6579
2020
Q1 		– Hold
0
– – – 6609
2019
Q4 		– Sell
-1
Closed -$21 – 6767
2019
Q3 		$0 Hold
1
– – ﹤0.01% 6639
2019
Q2 		$0 Sell
1
-1
-50% -$71 ﹤0.01% 6818
2019
Q1 		$0 Hold
2
– – ﹤0.01% 6761
2018
Q4 		$0 Hold
2
– – ﹤0.01% 6688
2018
Q3 		$0 Sell
2
-50
-96% -$3.16K ﹤0.01% 6672
2018
Q2 		$4K Buy
52
+51
+5,100% +$10.4K ﹤0.01% 6085
2018
Q1 		$0 Hold
1
– – ﹤0.01% 6285
2017
Q4 		$0 Sell
1
-1
-50% -$320 ﹤0.01% 6490
2017
Q3 		$1K Sell
2
-5
-71% -$3.59K ﹤0.01% 6605
2017
Q2 		$5K Buy
7
+5
+250% +$4.05K ﹤0.01% 6022
2017
Q1 		$2K Sell
2
-1
-33% -$1.21K ﹤0.01% 6415
2016
Q4 		$3K Hold
3
– – ﹤0.01% 6400
2016
Q3 		$3K Hold
3
– – ﹤0.01% 6079
2016
Q2 		$5K Buy
3
+2
+200% +$4.18K ﹤0.01% 5940
2016
Q1 		$2K Hold
1
– – ﹤0.01% 6107
2015
Q4 		$4K Sell
1
-5
-83% -$21.1K ﹤0.01% 6203
2015
Q3 		$27K Sell
6
-8
-57% -$48.2K ﹤0.01% 5433
2015
Q2 		$69K Hold
14
– – ﹤0.01% 5041
2015
Q1 		$64K Buy
14
+11
+367% +$54K ﹤0.01% 4845
2014
Q4 		$15K Hold
3
– – ﹤0.01% 5480
2014
Q3 		$21K Sell
3
-1
-25% -$6.95K ﹤0.01% 5266
2014
Q2 		$32K Sell
4
-21
-84% -$258K ﹤0.01% 5039
2014
Q1 		$649K Sell
25
-5
-17% -$123K ﹤0.01% 3141
2013
Q4 		$544K Sell
30
-5
-14% -$87.7K ﹤0.01% 3342
2013
Q3 		$713K Buy
35
+3
+9% +$62.1K ﹤0.01% 3084
2013
Q2 		$682K Buy
+32
New +$716K ﹤0.01% 2873

Other funds holding ACHV

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's ACHV Position: Q1 2026 in Review

Royal Bank of Canada reduced its Achieve Life Sciences (ACHV) stake by 92% in Q1 2026, selling an estimated $6.26K and leaving 126 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7041.

Royal Bank of Canada first reported a position in ACHV in Q2 2013 and has held it in 41 quarters since. The position peaked at $713K in Q3 2013. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Royal Bank of Canada held 126 shares of Achieve Life Sciences worth $0 as of Q1 2026.
  • Royal Bank of Canada sold 1,410 Achieve Life Sciences shares in Q1 2026, an estimated $6.26K.
  • Achieve Life Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7041 holding.
  • Royal Bank of Canada first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 41 quarters since.
  • Royal Bank of Canada's Achieve Life Sciences position peaked at $713K in Q3 2013.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.